Therefore, we propose that the p97/UBXD1 axis represents a potential therapeutic target for DYT1 dystonia as its inhibition reduces K48-Ub accumulation inside blebs. The gene discussed is VCP; the disease is early-onset generalized limb-onset dystonia.